dihydroergotamine has been researched along with ergotamine in 117 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 59 (50.43) | 18.7374 |
1990's | 37 (31.62) | 18.2507 |
2000's | 11 (9.40) | 29.6817 |
2010's | 9 (7.69) | 24.3611 |
2020's | 1 (0.85) | 2.80 |
Authors | Studies |
---|---|
Boess, FG; Monsma, FJ; Sleight, AJ | 1 |
Dantzig, AH; Ekins, S; Kim, RB; Lan, LB; Leake, BF; Schuetz, EG; Schuetz, JD; Shepard, RL; Wikel, JH; Winter, MA; Wrighton, SA; Yasuda, K | 1 |
Furuya, K; Lan, LB; Sanglard, D; Schuetz, EG; Schuetz, JD; Yasuda, K | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Govoni, S; Iuliano, E; Spano, PF; Trabucchi, M | 1 |
Fanchamps, A | 2 |
Fozard, JR | 1 |
Berde, B | 1 |
Barolin, GS | 1 |
Kerekes, A; Policova, Z; Sirek, A; Sirek, OV | 1 |
Diamond, S | 1 |
Loeffler, LJ; Schran, HF; Schwarz, HJ; Talbot, KC | 1 |
Edvinsson, L; Hardebo, JE; Owman, C; Svendgaard, NA | 1 |
Müller-Schweinitzer, E | 2 |
Schwalb, H | 1 |
Nasr, H; Pearson, OH | 1 |
Wilkinson, M | 2 |
Stürmer, E | 2 |
Aellig, WH | 1 |
Bertorello, G; Bolis, PF; Zara, C | 1 |
Diener, HC; Grotemeyer, KH; Pfaffenrath, V; Soyka, D | 1 |
Liaño, H | 1 |
den Boer, MO; Saxena, PR; Somers, JA | 1 |
Wallasch, TM | 1 |
Ollat, H | 1 |
Creutzig, A | 1 |
Angus-Leppan, H; Boers, PM; Lambert, GA; Lowy, AJ; Zagami, AS | 1 |
Deliganis, AV; Peroutka, SJ | 1 |
den Boer, MO; Heiligers, JP; Saxena, PR | 1 |
Brown, AM; Kaumann, AJ; Patch, TL | 1 |
Bongard, O; Bounameaux, H | 1 |
Raskin, NH | 2 |
Bourin, M | 1 |
Cavanna, M | 1 |
Bousser, MG; Massiou, H | 1 |
Grenié, B; Roquebert, J | 1 |
Edmeads, JG | 1 |
Filinova, ZS | 1 |
Chan, PS; Ellenbogen, L | 1 |
Laron, Z; Silbergeld, AK | 1 |
Wichliński, L | 1 |
Kanto, J | 1 |
Vesely, DL | 1 |
Aupy, M; Henry, PY; Lafforgue, JL; Larre, P; Orgogozo, JM | 1 |
Eggers, C | 1 |
Damasio, H | 1 |
Andres, H; Bolliger, G; Gull, P; Munzer, H; Rosenthaler, J; Voges, R | 1 |
Saxena, PR; Spierings, EL | 2 |
Maendly, R; Martinez Lage, JM; Mumenthaler, M | 1 |
Durko, A; Głuszcz-Zielińska, A | 1 |
Titus, F | 3 |
Silberstein, SD; Young, WB | 1 |
Lipton, RB; Silberstein, SD | 1 |
Bax, WA | 1 |
Bax, WA; Ferrari, MD; Haan, J; Meijler, WJ; Timmerman, H; van Coevorden, RS | 1 |
Van Mil, JW | 1 |
Liaño, H; López-Zuazo, I | 1 |
Mathew, NT; Ravishankar, K; Sanin, LC | 1 |
Glusa, E; Roos, A | 1 |
Silberstein, SD | 1 |
Mathew, NT | 1 |
Lipton, RB | 1 |
Young, WB | 1 |
Kalkman, HO; Schneider, F | 1 |
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR | 1 |
Delemazure, B; Rozot, P; Sommer, S; Wagner, M; Xenard, L | 1 |
Centurión, D; De Vries, P; Rabelo, G; Sánchez-López, A; Saxena, P; Villalón, CM | 1 |
Noth, J | 1 |
Yamane, K | 1 |
Csiba, L; Ficzere, A | 1 |
Tfelt-Hansen, P | 1 |
Bigal, ME; Tepper, SJ | 1 |
McCrory, DC; Silberstein, SD | 1 |
HUTER, F; KRONEBERG, G; POTZSCH, E | 1 |
DALSGAARD-NIELSEN, T | 1 |
CHARONNAT, R; LECHAT, P | 1 |
TINDAL, JS | 1 |
CARPI, A; VIRNO, M | 1 |
LLOYD, S | 1 |
HAIST, RE; HAWKINS, RD | 1 |
BISHOP, JM; HARRIS, P; SEGEL, N | 1 |
CARRERASMATA, M | 1 |
GORDON, CJ | 1 |
NOVAK, S; VAJNORSKY, J | 1 |
BAUER, A | 1 |
LAGO, E; SPINATO, R | 1 |
BREHM, H; ROSMANITZ, J | 1 |
SCHMITT, H | 1 |
SIMKOVA, M | 2 |
HORTON, BT; PETERS, GA | 1 |
KLEIN, H; RIECHERT, W | 1 |
Callaway, TR; Edrington, TS; Looper, ML; Moubarak, AS; Rosenkrans, CF | 1 |
Johnson, ZB; Looper, ML; Rorie, RW; Rosenkrans, CF; Wang, H | 1 |
Autret-Leca, E; Beau-Salinas, F; Bensouda-Grimaldi, L; Cissoko, H; Jonville-Béra, AP | 1 |
ABREU, BE; LIDDLE, GW | 1 |
DANNENBERG, T | 1 |
Peatfield, R | 1 |
Dahlöf, C; Maassen Van Den Brink, A | 1 |
Rapoport, AM | 1 |
Goadsby, PJ; Mathias, CJ; Viana, M | 1 |
Bai, F; Cherezov, V; Gao, X; Han, GW; Huang, XP; Jiang, H; Jiang, Y; Katritch, V; Liu, W; Ma, J; McCorvy, JD; Melcher, K; Roth, BL; Stevens, RC; Vardy, E; Wacker, D; Wang, C; Wu, H; Xu, HE; Yang, H; Yang, L; Zhang, C; Zhou, XE | 1 |
Kiser, PD; Palczewski, K | 1 |
Havemann, J; Keller, U; Loll, B; Vogel, D | 1 |
Campbell, A; Floyd, C; Moore, K; Sullivan, HJ; Tursi, A; Wu, C | 1 |
27 review(s) available for dihydroergotamine and ergotamine
Article | Year |
---|---|
The animal pharmacology of drugs used in the treatment of migraine.
Topics: Acetaminophen; Adrenergic alpha-Antagonists; Analgesics; Animals; Aspirin; Caffeine; Clonidine; Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Monoamine Oxidase Inhibitors; Muscle, Smooth; Pizotyline; Serotonin Antagonists; Sympathetic Nervous System; Synaptic Transmission; Tryptamines; Vagus Nerve; Vasoconstrictor Agents; Vasodilator Agents | 1975 |
[Classification, pathogenesis and drug therapy of migraine and related forms of headache].
Topics: Adrenergic beta-Antagonists; Animals; Caffeine; Clonidine; Dihydroergotamine; Drug Synergism; Epinephrine; Ergotamine; Headache; Histamine; Humans; Methysergide; Mice; Migraine Disorders; Norepinephrine; Pizotyline; Serotonin | 1975 |
Pharmacology of ergot alkaloids in clinical use.
Topics: Animals; Brain Diseases; Bromocriptine; Dihydroergotamine; Dihydroergotoxine; Dopamine Antagonists; Ergot Alkaloids; Ergotamine; Female; Humans; Methysergide; Migraine Disorders; Parkinson Disease; Pituitary Gland; Prolactin; Receptors, Adrenergic; Receptors, Dopamine; Uterus; Vasoconstriction | 1978 |
[Current treatment of migraine].
Topics: Adult; Child; Dihydroergotamine; Ergotamine; Female; Humans; Indoles; Male; Methysergide; Metoclopramide; Middle Aged; Migraine Disorders; Sulfonamides; Sumatriptan; Time Factors; Vasoconstrictor Agents | 1992 |
[Drug-induced headache].
Topics: Analgesics; Analgesics, Opioid; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders | 1992 |
[Serotonin agonists and antagonists in migraine].
Topics: Benzoxepins; Contraindications; Cyproheptadine; Dihydroergotamine; Ergotamine; Histamine H1 Antagonists; Humans; Indoles; Methysergide; Migraine Disorders; Phenothiazines; Pizotyline; Receptors, Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
Modern pharmacotherapy of migraine.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Chlorpromazine; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Prochlorperazine; Valproic Acid | 1990 |
[Therapy of headache].
Topics: Cluster Headache; Dextropropoxyphene; Dihydroergotamine; Domperidone; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Pizotyline; Prednisolone; Prednisone; Vascular Headaches | 1989 |
Migraine.
Topics: Acute Disease; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Analgesics; Calcium Channel Blockers; Chlorpromazine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Narcotics; Pizotyline | 1988 |
Clinical pharmacokinetics of ergotamine, dihydroergotamine, ergotoxine, bromocriptine, methysergide, and lergotrile.
Topics: Absorption; Animals; Bromocriptine; Dihydroergotamine; Ergolines; Ergot Alkaloids; Ergotamine; Half-Life; Humans; Kinetics; Methysergide | 1983 |
[Treatment of the acute migraine attack].
Topics: Acute Disease; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1995 |
Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology.
Topics: Dihydroergotamine; Ergotamine; Humans; Migraine Disorders | 1995 |
Migraine treatment: the British perspective.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan; United Kingdom | 1994 |
Overview of diagnosis and treatment of migraine.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Antagonists; Sumatriptan | 1994 |
Acute and prophylactic treatment of migraine: practical approaches and pharmacologic rationale.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Phenothiazines; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Valproic Acid | 1993 |
[Symptomatic treatment of cluster headache].
Topics: Alkaloids; Analgesics; Capsaicin; Cluster Headache; Cocaine; Dihydroergotamine; Ergotamine; Humans; Lidocaine; Methoxyflurane; Narcotics; Oxygen; Sumatriptan; Vasoconstrictor Agents | 1995 |
[Prophylactic treatment of episodic forms of cluster headache].
Topics: Adrenal Cortex Hormones; Alkaloids; Calcium Channel Blockers; Capsaicin; Cluster Headache; Dihydroergotamine; Ergotamine; Humans; Lithium; Methysergide; Serotonin Antagonists; Tranquilizing Agents; Vasoconstrictor Agents | 1995 |
The pharmacology of ergotamine and dihydroergotamine.
Topics: Analgesics, Non-Narcotic; Body Fluids; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Receptors, Serotonin; Structure-Activity Relationship | 1997 |
Dosing and administration of ergotamine tartrate and dihydroergotamine.
Topics: Analgesics, Non-Narcotic; Cluster Headache; Dihydroergotamine; Dosage Forms; Ergotamine; Humans; Migraine Disorders; Nausea; Suppositories; Tablets; Vomiting | 1997 |
Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
Topics: Administration, Intranasal; Analgesics, Non-Narcotic; Animals; Consumer Product Safety; Dihydroergotamine; Drug Monitoring; Ergotamine; Humans; Migraine Disorders; Nausea; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic | 1997 |
[Migraine: selection of therapeutic agents to be applied during its attack].
Topics: Analgesics; Antiemetics; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Sumatriptan | 2001 |
[Treatment of migraine in patients with hypertension and ischemic heart disease].
Topics: Adjuvants, Pharmaceutic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Contraindications; Dihydroergotamine; Dopamine Agonists; Ergotamine; Humans; Hypertension; Indoles; Migraine Disorders; Myocardial Ischemia; Oxazolidinones; Retrospective Studies; Serotonin Receptor Agonists; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 2002 |
Ergotamine, dihydroergotamine: current uses and problems.
Topics: Analgesics, Non-Narcotic; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Sumatriptan | 2001 |
Ergotamine and dihydroergotamine: a review.
Topics: Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Humans; Migraine Disorders; Randomized Controlled Trials as Topic; Sumatriptan; Treatment Outcome | 2003 |
Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
Topics: Animals; Dihydroergotamine; Ergotamine; History, 19th Century; History, 20th Century; Humans; Migraine Disorders; Receptors, Serotonin; Treatment Outcome; United States; Vasoconstrictor Agents | 2003 |
Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Topics: Animals; Dihydroergotamine; Ergotamine; Humans; Methysergide; Migraine Disorders; Sumatriptan; Treatment Outcome | 2012 |
What happens to the old headache medicines?
Topics: Analgesics; Clinical Trials as Topic; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Tryptamines | 2012 |
90 other study(ies) available for dihydroergotamine and ergotamine
Article | Year |
---|---|
Identification of residues in transmembrane regions III and VI that contribute to the ligand binding site of the serotonin 5-HT6 receptor.
Topics: Adenylyl Cyclases; Amino Acid Substitution; Binding Sites; Binding, Competitive; Cell Line; Cyclic AMP; Humans; Ligands; Lysergic Acid Diethylamide; Mutagenesis, Site-Directed; Mutation; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1998 |
Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Ergonovine; Fluoxetine; Humans; Models, Molecular; Oxytocics; Protein Conformation; Selective Serotonin Reuptake Inhibitors; Structure-Activity Relationship; Swine; Transfection; Vinblastine | 2002 |
Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Line; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dihydroergocryptine; Drug Interactions; Enzyme Inhibitors; Fluconazole; Humans; Mice; Mice, Knockout; Microsomes, Liver; Oxidoreductases, N-Demethylating; Recombinant Proteins; Reserpine; Swine; Tissue Distribution; Transfection; Vinblastine | 2002 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effect of ergotamine and dihydroergotamine on dopamine-stimulated adenylate cyclase in rat caudate nucleus.
Topics: Adenylyl Cyclases; Animals; Apomorphine; Caudate Nucleus; Dihydroergotamine; Dopamine; Drug Interactions; Ergotamine; Ergotamines; In Vitro Techniques; Rats; Stimulation, Chemical | 1977 |
[Mechanism of action of drugs currently used in the prevention of migraine].
Topics: Adrenergic beta-Antagonists; Catecholamines; Cerebrovascular Circulation; Chemical Phenomena; Chemistry; Clonidine; Dihydroergotamine; Ergotamine; Histamine Release; Humans; Kinins; Methysergide; Migraine Disorders; Pizotyline; Serotonin Antagonists | 1976 |
[Drug therapy for headache: (author's transl)].
Topics: Analgesics; Anti-Inflammatory Agents; Antidepressive Agents; Clonidine; Dihydroergotamine; Ergotamine; Headache; Humans; Migraine Disorders; Neuralgia; Pizotyline; Sleep; Substance-Related Disorders; Tranquilizing Agents | 1977 |
Effect of ergot alkaloids on sulfonylurea-stimulated insulin secretion in dogs.
Topics: Animals; Blood Glucose; Dihydroergotamine; Dihydroergotoxine; Dogs; Ergonovine; Ergot Alkaloids; Ergotamine; Female; Injections, Intravenous; Insulin; Insulin Secretion; Male; Secretory Rate; Sulfonylurea Compounds | 1977 |
Cluster headache: relation to and comparison with migraine.
Topics: Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Humans; Male; Methysergide; Migraine Disorders; Prednisone; Vascular Headaches | 1979 |
Specific radioimmunoassay of ergot peptide alkaloids in plasma.
Topics: Bromocriptine; Cross Reactions; Dihydroergotamine; Ergolines; Ergotamine; Humans; Radioimmunoassay; Structure-Activity Relationship | 1979 |
Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
Topics: Animals; Arteries; Cats; Cerebral Arteries; Cyproheptadine; Dihydroergotamine; Drug Synergism; Ergotamine; Humans; In Vitro Techniques; Methysergide; Migraine Disorders; Pizotyline; Serotonin; Serotonin Antagonists; Vasoconstriction; Vasomotor System | 1978 |
Studies on the 5-HT receptor in vascular smooth muscle.
Topics: Animals; Basilar Artery; Cattle; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; In Vitro Techniques; Methysergide; Muscle, Smooth; Pizotyline; Receptors, Serotonin; Thiophenes | 1978 |
[Letter: Coronary spasm following ergotamine medication].
Topics: Adult; Angina Pectoris; Coronary Disease; Coronary Vessels; Dihydroergotamine; Ergotamine; Headache; Humans; Male; Migraine Disorders | 1975 |
Inhibition of prolactin secretion by ergot alkaloids.
Topics: Animals; Depression, Chemical; Dihydroergotamine; Dihydroergotoxine; Ergolines; Ergot Alkaloids; Ergotamine; Estradiol; Estrus; Female; Mammary Neoplasms, Experimental; Perphenazine; Pituitary Gland; Pregnancy; Prolactin; Rats | 1975 |
[The use of drugs in migraine].
Topics: Acetaminophen; Antiemetics; Aspirin; Clonidine; Dihydroergotamine; Ergotamine; Humans; Hypnotics and Sedatives; Methysergide; Migraine Disorders; Tranquilizing Agents | 1976 |
Effects of ergotamine and dihydroergotamine on the resistance and capacitance vessels of skin and skeletal muscle in the cat.
Topics: Animals; Blood Vessels; Cats; Dihydroergotamine; Ergotamine; Ergotamines; Male; Muscle Tonus; Muscle, Smooth; Muscles; Skin | 1976 |
Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
Topics: Animals; Blood Pressure; Blood Vessels; Cats; Dihydroergotamine; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Ergot Alkaloids; Ergotamine; Female; Femoral Vein; Humans; Leg; Male; Muscle Contraction; Muscles; Norepinephrine; Phentolamine; Saphenous Vein; Vascular Resistance; Veins | 1976 |
[Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
Topics: Blood Pressure; Dihydroergotamine; Dose-Response Relationship, Drug; Ergot Alkaloids; Ergotamine; Hand; Humans; Methysergide; Vascular Resistance; Veins | 1976 |
[The use of dihydroergotamine and chlorpromazine in labor induction].
Topics: Adult; Chlorpromazine; Dihydroergotamine; Ergotamine; Ergotamines; Female; Humans; Infusions, Parenteral; Labor, Induced; Pregnancy | 1976 |
[Treatment of cluster headache. Recommendations of the German Migraine and Headache Society].
Topics: Cluster Headache; Combined Modality Therapy; Dihydroergotamine; Ergotamine; Humans; Indoles; Lidocaine; Oxygen Inhalation Therapy; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1992 |
Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
Topics: Animals; Arteriovenous Anastomosis; Dihydroergotamine; Dura Mater; Ergotamine; Hemodynamics; Indoles; Microspheres; Migraine Disorders; Regional Blood Flow; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents | 1992 |
[Ergotamine-induced heart valve fibrosis and coronary microangiopathy?].
Topics: Coronary Disease; Dihydroergotamine; Ergotamine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Male; Middle Aged; Mitral Valve Insufficiency | 1992 |
The spinal cord processing of input from the superior sagittal sinus: pathway and modulation by ergot alkaloids.
Topics: Action Potentials; Animals; Cats; Cranial Sinuses; Dihydroergotamine; Electric Stimulation; Ergonovine; Ergotamine; Evoked Potentials; Neural Pathways; Spinal Cord | 1992 |
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Ergotamine; Indoles; Kinetics; Methysergide; Migraine Disorders; Radioligand Assay; Receptors, Serotonin; Serotonin; Sulfonamides; Sumatriptan; Vasoconstrictor Agents; Verapamil | 1991 |
Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
Topics: Animals; Arteriovenous Anastomosis; Brain Chemistry; Carotid Arteries; Coronary Circulation; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; Hemodynamics; Indoles; Methiothepin; Muscle, Smooth, Vascular; Oxygen Consumption; Receptors, Serotonin; Sulfonamides; Sumatriptan; Swine; Vasoconstrictor Agents | 1991 |
The antimigraine drugs ergotamine and dihydroergotamine are potent 5-HT1C receptor agonists in piglet choroid plexus.
Topics: Animals; Binding, Competitive; Choroid Plexus; Dihydroergotamine; Ergolines; Ergotamine; In Vitro Techniques; Inositol Phosphates; Migraine Disorders; Piperazines; Receptors, Serotonin; Serotonin; Swine; Thermodynamics | 1991 |
Severe iatrogenic ergotism: incidence and clinical importance.
Topics: Adolescent; Adult; Arm; Dihydroergotamine; Drug Combinations; Ergotamine; Ergotamines; Ergotism; Female; Heparin; Heparin, Low-Molecular-Weight; Humans; Iatrogenic Disease; Leg; Male; Middle Aged; Nifedipine; Nitroprusside | 1991 |
[Serotonin and antiserotonergic agents].
Topics: Cyproheptadine; Dihydroergotamine; Ergotamine; Humans; Methysergide; Pizotyline; Serotonin; Serotonin Antagonists | 1990 |
[Antimigrainous agents. General considerations and treatment of the crisis].
Topics: Acupuncture Therapy; Amitriptyline; Analgesics; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antiemetics; Caffeine; Dihydroergotamine; Ergotamine; Ergotamines; Humans; Migraine Disorders | 1986 |
Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Decerebrate State; Dihydroergotamine; Electric Stimulation; Ergotamine; Hemodynamics; Male; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1986 |
Effect of dihydroergotamine on partial functions of the kidneys and water and salt metabolism in dogs with experimental hypertension.
Topics: Animals; Dihydroergotamine; Disease Models, Animal; Diuresis; Dogs; Ergotamine; Glomerular Filtration Rate; Hypertension; Kidney; Natriuresis; Pituitary Hormones, Posterior; Sodium; Vasomotor System; Water-Electrolyte Balance | 1974 |
New evidence for the beta-adrenergic receptor blocking activity of dihydroergotamine.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Anura; Blood Proteins; Carbon Radioisotopes; Catecholamines; Chromatography; Cyclic AMP; Dihydroergotamine; Dose-Response Relationship, Drug; Enzyme Activation; Ergotamine; Erythrocytes; Female; Fluorides; In Vitro Techniques; Isoproterenol; Male; Phentolamine; Phosphoric Diester Hydrolases; Propranolol; Rana pipiens; Tritium | 1974 |
Lipolytic effects of sheep beta-lipotropin in rat adipose tissue: interaction with theophylline and dihydroergotamine.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Animals; beta-Lipotropin; Cycloheximide; Dexamethasone; Dihydroergotamine; Ergotamine; Fasting; Fatty Acids; Glycerol; Growth Hormone; Humans; In Vitro Techniques; Lipid Mobilization; Male; Rats; Sheep; Theophylline; Time Factors; Triglycerides | 1974 |
[Effect of ascorbic acid on stability of dihydroergotamine solutions].
Topics: Ascorbic Acid; Dihydroergotamine; Drug Stability; Ergotamine; Solutions | 1974 |
Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
Topics: Animals; Cyclic GMP; Dihydroergotamine; Ergotamine; Guanylate Cyclase; In Vitro Techniques; Male; Manganese; Radioimmunoassay; Rats; Rats, Inbred Strains | 1983 |
Reversible cerebral arteriopathy associated with the administration of ergot derivatives.
Topics: Adult; Anti-Bacterial Agents; Cerebral Arterial Diseases; Dihydroergotamine; Dose-Response Relationship, Drug; Drug Interactions; Ergotamine; Ergotamines; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Methylergonovine; Norgestrel | 1984 |
[Headache in children].
Topics: Brain Neoplasms; Child; Child, Preschool; Contusions; Dihydroergotamine; Ergotamine; Headache; Humans; Hypertension, Renal; Migraine Disorders; Prognosis; Propranolol; Vascular Headaches | 1984 |
Drug management of adult vascular headaches (migraine and cluster headache): Part I--Treatment of the acute attack.
Topics: Cluster Headache; Dihydroergotamine; Ergotamine; Humans; Metoclopramide; Migraine Disorders; Vascular Headaches | 1984 |
Immunoassay of ergotamine and dihydroergotamine using a common 3H-labelled ligand as tracer for specific antibody and means to overcome experienced pitfalls.
Topics: Dihydroergotamine; Ergotamine; Humans; Radioimmunoassay; Tritium | 1984 |
Vascular effects of ergot alkaloids: a study on human basilar arteries.
Topics: Basilar Artery; Cocaine; Dihydroergotamine; Ergot Alkaloids; Ergotamine; Humans; In Vitro Techniques; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Serotonin | 1983 |
Pharmacology of arteriovenous anastomoses.
Topics: Animals; Arteriovenous Anastomosis; Cats; Cerebrovascular Circulation; Dihydroergotamine; Ergotamine; Humans; Methylamines; Methysergide; Migraine Disorders; Sympathomimetics | 1982 |
[Erythroprosopalgia. Review including 224 own observations].
Topics: Adult; Age Factors; Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Humans; Indomethacin; Lithium; Male; Methysergide; Middle Aged; Prednisone; Sex Factors; Trigeminal Neuralgia; Vascular Headaches | 1982 |
Antimigraine drugs and cranial arteriovenous shunting in the cat.
Topics: Animals; Arteriovenous Shunt, Surgical; Blood Gas Analysis; Carotid Arteries; Cats; Cerebrovascular Circulation; Dihydroergotamine; Ergotamine; Migraine Disorders; Oxygen; Skull | 1980 |
Management of migraine.
Topics: Analgesics; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders | 1981 |
[Complications in the treatment of migraine with ergotamine and its derivatives].
Topics: Adult; Dihydroergotamine; Ergotamine; Ergotism; Female; Humans; Ischemia; Leg; Migraine Disorders; Vasoconstrictor Agents | 1981 |
Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology.
Topics: Dihydroergotamine; Ergotamine; Humans; Migraine Disorders | 1995 |
[Multiple value of sumatriptan above that of ergot alkaloids still not proven].
Topics: Coronary Vessels; Dihydroergotamine; Ergotamine; Humans; Sumatriptan | 1994 |
[Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Vasoconstrictor Agents | 1993 |
[Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Topics: Dihydroergotamine; Ergotamine; Humans; Indoles; Migraine Disorders; Serotonin Receptor Agonists; Sulfonamides; Sumatriptan; Therapeutic Equivalency; Vasoconstrictor Agents | 1993 |
Coexistence of migraine and idiopathic intracranial hypertension without papilledema.
Topics: Acetazolamide; Adolescent; Adult; Dihydroergotamine; Diuretics; Ergotamine; Female; Follow-Up Studies; Furosemide; Headache; Humans; Intracranial Pressure; Male; Middle Aged; Migraine Disorders; Obesity; Papilledema; Pseudotumor Cerebri; Sumatriptan | 1996 |
Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine.
Topics: Adrenergic alpha-Antagonists; Animals; Dihydroergotamine; Dinoprost; Endothelium, Vascular; Ergotamine; Humans; In Vitro Techniques; Muscle Relaxation; Pulmonary Artery; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swine; Vasoconstrictor Agents; Yohimbine | 1996 |
Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
Topics: Analgesics, Non-Narcotic; Contraindications; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Practice Guidelines as Topic | 1997 |
Effects of ergotamine and dihydroergotamine on 5-hydroxytryptamine-2A receptors in the isolated rat aorta.
Topics: Animals; Aorta; Dihydroergotamine; Dose-Response Relationship, Drug; Ergotamine; In Vitro Techniques; Male; Rats; Rats, Inbred WKY; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin; Vasoconstrictor Agents | 1996 |
[The treatment of migraine].
Topics: Adrenergic beta-Antagonists; Amitriptyline; Calcium Channel Blockers; Dihydroergotamine; Ergotamine; Flunarizine; Humans; Methysergide; Migraine Disorders; Nicardipine; Nimodipine; Serotonin Antagonists; Serotonin Receptor Agonists; Sumatriptan; Vasoconstrictor Agents | 1997 |
Coronary side-effect potential of current and prospective antimigraine drugs.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents | 1998 |
[Bilateral ischemic optic neuropathy secondary to acute ergotism].
Topics: Adult; Anti-Bacterial Agents; Dihydroergotamine; Ergotamine; Ergotism; Humans; Hypertension; Macrolides; Male; Migraine Disorders; Optic Neuropathy, Ischemic; Vasoconstrictor Agents; Visual Acuity | 1998 |
New "triptans" and other drugs for migraine.
Topics: Adrenergic beta-Antagonists; Amitriptyline; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; Calcium Channel Blockers; Dihydroergotamine; Drug Interactions; Ergotamine; Humans; Indoles; Methysergide; Migraine Disorders; Naproxen; Oxazoles; Oxazolidinones; Piperidines; Propranolol; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Sumatriptan; Time Factors; Timolol; Triazoles; Tryptamines; Valproic Acid; Vasoconstrictor Agents | 1998 |
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Flow Velocity; Carotid Arteries; Clonidine; Dihydroergotamine; Dogs; Ergotamine; Female; Hemodynamics; Male; Methysergide; Oxadiazoles; Phenylephrine; Piperazines; Prazosin; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Serotonin Antagonists; Sumatriptan; Vasoconstriction; Vasoconstrictor Agents; Yohimbine | 1999 |
[Migraine treatment].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Dihydroergotamine; Drug Therapy, Combination; Ergotamine; Humans; Migraine Disorders; Serotonin Receptor Agonists; Severity of Illness Index; Vasoconstrictor Agents | 2000 |
Fibrosis due to ergot derivatives: exposure to risk should be weighed up.
Topics: Dihydroergotamine; Ergotamine; Fibrosis; France; Humans; Methysergide; Risk Assessment; Risk Factors | 2002 |
[Effects of ergotamine, dihydroergotamine and hydergin on the physiology of thyroxin in guinea pig].
Topics: Cardiovascular Agents; Dihydroergotamine; Ergot Alkaloids; Ergotamine; Guinea Pigs; Oxytocics; Thyroxine | 1952 |
[Ergotamine-caffeine and dihydroergotamine-caffeine in migraine therapy].
Topics: Caffeine; Dihydroergotamine; Drug Combinations; Ergot Alkaloids; Ergotamine; Humans; Migraine Disorders; Oxytocics | 1952 |
[Utilization of corneal anesthesia for differentiation of two similar products: ergotamine and dihydroergotamine].
Topics: Anesthesia; Anesthetics; Anesthetics, Local; Cardiovascular Agents; Cornea; Dihydroergotamine; Ergot Alkaloids; Ergotamine; Humans; Oxytocics | 1955 |
The effect of ergotamine and dihydroergotamine on lactation in the rat.
Topics: Animals; Dihydroergotamine; Ergot Alkaloids; Ergotamine; Female; Humans; Lactation; Rats | 1956 |
The action of ergotamine on the intracranial venous pressure and on the cerebral venous outflow of the dog.
Topics: Animals; Brain; Cerebral Veins; Cerebrovascular Circulation; Dihydroergotamine; Dogs; Ergot Alkaloids; Ergotamine; Hypertension; Intracranial Pressure; Migraine Disorders; Vasoconstriction; Vasoconstrictor Agents; Venous Pressure | 1957 |
Vascular responses of the rat to bradykinin.
Topics: Animals; Atropine; Blood Pressure; Bradykinin; Diethylstilbestrol; Dihydroergotamine; Ergotamine; Estrogens; Estrus; Female; Hexamethonium Compounds; Male; Oxytocin; Rats | 1962 |
THE EFFECT OF ADRENALECTOMY, DIHYDROERGOTAMINE, AND DIBENZYLINE ON THE SENSITIVITY OF RATS TO TOLBUTAMIDE.
Topics: Adrenalectomy; Blood Glucose; Dihydroergotamine; Ergotamine; Pharmacology; Phenoxybenzamine; Rats; Research; Tolbutamide | 1963 |
THE EFFECTS OF DIHYDROERGOTAMINE TARTRATE ON THE PULMONARY AND SYSTEMIC CIRCULATIONS IN MAN.
Topics: Blood Pressure; Blood Pressure Determination; Dihydroergotamine; Ergotamine; Heart; Pharmacology; Pulmonary Circulation; Respiration; Tartrates | 1963 |
"RETINAL REANIMATION" IN THE SURGICAL TREATMENT OF GLAUCOMA: FIRST RESULTS OBTAINED WITH THE POSTOPERATIVE ADMINISTRATION OF DIHYDROERGOTAMINE (DHE).
Topics: Dihydroergotamine; Ergotamine; Geriatrics; Glaucoma; Humans; Postoperative Period; Retina; Retinal Vessels; Surgical Procedures, Operative; Visual Fields | 1964 |
[TREATMENT OF HERPES WITH DIHYDROERGOTAMINE].
Topics: Adolescent; Child; Dihydroergotamine; Ergotamine; Geriatrics; Herpes Zoster; Herpesvirus 3, Human; Humans; Infant | 1963 |
[OUR EXPERIENCES WITH DIHYDROERGOTAMINE SPOFA THERAPY IN CEPHALALGIA IN CHILDREN].
Topics: Adolescent; Autonomic Nervous System Diseases; Child; Dihydroergotamine; Ergotamine; Headache; Humans; Infant; Vasomotor System | 1964 |
[SYMPTOMATIC CHANGES AND PROVOCATION OF SYMPTOMS IN THE MANAGEMENT OF AFFECTIVE PSYCHOSIS WITH DELIRIOGENIC SUBSTANCES PROTECTED BY METHANESULFONIC ACID DIHYDROERGOTAMINE].
Topics: Dihydroergotamine; Ergotamine; Hallucinogens; Mental Disorders; Mesylates; Parasympatholytics; Psychopharmacology; Psychotic Disorders; Toxicology | 1964 |
[NEW EXPERIENCES WITH DIHYDROERGOTAMINE AND LARGACTIL MIXTURE IN OBSTETRICS].
Topics: Chlorpromazine; Dihydroergotamine; Ergotamine; Female; Humans; Labor, Induced; Labor, Obstetric; Obstetrics; Pregnancy | 1964 |
[CLINICAL-EXPERIMENTAL STUDY OF THE CIRCULATORY EFFECT OF DIHYDERGOT IN THE ORTHOSTATIC SYNDROME].
Topics: Dihydroergotamine; Drug Therapy; Ergotamine; Humans; Hypotension; Hypotension, Orthostatic; Posture; Syndrome | 1964 |
[Action of ergotamine, dihydroergotamine and hydergine in the reserpine-treated rabbit].
Topics: Animals; Blood Pressure; Blood Pressure Determination; Cardiovascular Agents; Dihydroergotamine; Ergoloid Mesylates; Ergot Alkaloids; Ergotamine; Oxytocics; Pressure; Rabbits; Reserpine | 1959 |
[Therapy of herpetic diseases of the cornea with dihydroergotamine and gynergen].
Topics: Cornea; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Humans | 1950 |
Headache; with special reference to the excessive use of ergotamine tartrate and dihydroergotamine.
Topics: Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Headache | 1950 |
[Effects of ergotamine, dihydroergotamine and hydergine on egg white edema of the rat].
Topics: Animals; Dihydroergotamine; Edema; Egg White; Ergoloid Mesylates; Ergotamine; Hypersensitivity; Immune System Diseases; Rats | 1951 |
[Therapy of herpetic infections of the eyes; therapy with gynergen and dihydroergotamine Sandoz].
Topics: Cornea; Dihydroergotamine; Ergot Alkaloids; Ergotamine; Eye | 1950 |
Effects of the ergot alkaloids dihydroergotamine, ergonovine, and ergotamine on growth of Escherichia coli O157:H7 in vitro.
Topics: Analysis of Variance; Animals; Cattle; Cattle Diseases; Colony Count, Microbial; Dihydroergotamine; Ergonovine; Ergotamine; Escherichia coli Infections; Escherichia coli O157; Festuca; Food Microbiology; Regression Analysis; Rumen | 2008 |
Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.
Topics: Animals; Cattle; Chelating Agents; Cholera Toxin; Cyclic AMP; Dihydroergotamine; Egtazic Acid; Ergot Alkaloids; Ergotamine; Male; Pertussis Toxin; Prazosin; Receptors, Adrenergic, alpha; Signal Transduction; Sperm Motility; Spermatozoa; Yohimbine | 2009 |
Drug dependence associated with triptans and ergot derivatives: a case/non-case study.
Topics: Claviceps; Dihydroergotamine; Ergotamine; Humans; Migraine Disorders; Oxazolidinones; Piperidines; Pyrrolidines; Risk; Substance-Related Disorders; Sumatriptan; Tryptamines | 2010 |
Preliminary observations on the influence of ergotamine and dihydroergotamine on cerebral blood flow in the dog.
Topics: Animals; Cerebrovascular Circulation; Dihydroergotamine; Dogs; Ergotamine; Humans; Vasoconstrictor Agents | 1947 |
Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
Topics: Claviceps; Dihydroergotamine; Ergonovine; Ergot Alkaloids; Ergotamine; Migraine Disorders | 1946 |
Headache currents commentary.
Topics: Analgesics; Animals; Dihydroergotamine; Ergotamine; Headache; Humans; Methysergide; Migraine Disorders; Sumatriptan | 2012 |
Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine.
Topics: Adult; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Dihydroergotamine; Ergotamine; Female; Flushing; Headache; Humans; Hypohidrosis; Middle Aged; Migraine Disorders; Nitroglycerin; Sumatriptan; Vasoconstrictor Agents; Vasodilator Agents | 2012 |
Structural basis for molecular recognition at serotonin receptors.
Topics: Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Dihydroergotamine; Ergotamine; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Ligands; Lysergic Acid Diethylamide; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Mutagenesis; Norfenfluramine; Pindolol; Propranolol; Protein Conformation; Protein Folding; Protein Structure, Secondary; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists; Tryptamines | 2013 |
Biochemistry. As good as chocolate.
Topics: Dihydroergotamine; Ergotamine; Humans; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2B; Serotonin 5-HT1 Receptor Agonists | 2013 |
Cyclolization of D-lysergic acid alkaloid peptides.
Topics: Biocatalysis; Claviceps; Cyclization; Dihydroergotamine; Dioxygenases; Ergolines; Ergotamine; Humans; Hydroxylation; Lysergic Acid; Mixed Function Oxygenases; Models, Molecular; Peptide Synthases; Peptides; Protein Conformation | 2014 |
Binding Interactions of Ergotamine and Dihydroergotamine to 5-Hydroxytryptamine Receptor 1B (5-HT
Topics: Dihydroergotamine; Ergotamine; Molecular Dynamics Simulation; Receptors, Serotonin; Serotonin | 2020 |